Sobi (Swedish Orphan Biovitrum) Deal History & Licensing Activity
Sobi (Swedish Orphan Biovitrum) is a life sciences. Over the past three years, Sobi (Swedish Orphan Biovitrum) has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Other
Focus Area
Mega Deals
Sobi (Swedish Orphan Biovitrum) Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Sobi (Swedish Orphan Biovitrum) in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Arthrosi gout program | Sobi | Other | Unknown | acquisition | May 2026 |
Sobi (Swedish Orphan Biovitrum) Pipeline Focus
Therapeutic areas and modalities where Sobi (Swedish Orphan Biovitrum) is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Sobi (Swedish Orphan Biovitrum) Strategic Signals
Key indicators of Sobi (Swedish Orphan Biovitrum)'s licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Sobi (Swedish Orphan Biovitrum)'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Sobi (Swedish Orphan Biovitrum) Licensing & Deal Activity
Sobi (Swedish Orphan Biovitrum) is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Sobi (Swedish Orphan Biovitrum) ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sobi (Swedish Orphan Biovitrum) include Mega Deals (2 deals and trials). In terms of modality, Sobi (Swedish Orphan Biovitrum) has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sobi (Swedish Orphan Biovitrum) and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sobi (Swedish Orphan Biovitrum)'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.